medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
胶质细胞瘤
前庭神经鞘瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
神经细胞瘤
神经内分泌肿瘤
内分泌
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
甲状旁腺肿瘤
胸腺肿瘤
神经内分泌肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
壶腹肿瘤
肝胆癌
结直肠肿瘤
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
输卵管癌
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
性索间质瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
其他
症状管理
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
皮肤肿瘤
黑色素瘤
头颈部肿瘤
康复营养
生育能力
体力活动
心理健康
腹膜肿瘤
实体瘤
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
老年肿瘤
儿童/青少年肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
109条
与
Chemotherapy
有关的结果
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man
2019年 发布于
Gynecol Obstet Fertil Senol
47卷 第2期
所属人体系统:
生殖
|
卵巢肿瘤
FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique)
Au CNGOF (Collège National Des Gynécologues Obstétriciens Français)
À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).
Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert
a Subjective Analysis Is Optimal. If Performed by a Non-expert
Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert)
a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert
a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading
the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian
Fallopian Tube Or Primary Peritoneal Cancer
It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2
Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency
GFR <30mL/min)
an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3
Grade C). by Analogy
the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant
Chemotherapy
(LP3
Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3
Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa
2019年 发布于
Eur J Obstet Gynecol Reprod Biol
236卷 第_期
所属人体系统:
生殖
|
卵巢肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). Adjuvant
Chemotherapy
by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancers (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete
6 Cycles of Intravenous
Chemotherapy
(grade A) Are Recommended
Or a Discussion with the Patient About Intraperitoneal
Chemotherapy
According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease
Hyperthermic Intraperitoneal
Chemotherapy
(HIPEC) Can Be Proposed
in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors
Chemotherapy
Associated with Bevacizumab Is Recommended (grade A).
指南简介
原文链接
Consensus on Management of Castration-resistant Prostate Cancer on Behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology
2019年 发布于
Clin Transl Oncol
21卷 第1期
所属人体系统:
生殖
|
前列腺肿瘤
Urological Tumours Working Group
Ablative Treatments
Chemotherapy
Colorectal Cancer
Frail Patients
Metastases
Surgery
Targeted Agents
指南简介
原文链接
Metastatic Colorectal Cancer (mCRC): French Intergroup Clinical Practice Guidelines for Diagnosis, Treatments and Follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
2019年 发布于
Digestive and Liver Disease
51卷 第10期
所属人体系统:
消化
|
结直肠肿瘤
French Society of Gastroenterology
French-speaking Federation of Digestive Cancerology
Groupe Coopérateur Multidisciplinaire En Oncologie
Fédération Nationale Des Centres De Lutte Contre Le Cancer
Société Française De Chirurgie Digestive
Société Française D'Endoscopie Digestive
Société Française De Radiothérapie Oncologique
Société Française De Radiologie
Chemotherapy
Colorectal Cancer
French Clinical Practice Guidelines
Metastatic Hepatic Metastases Surgery
Targeted Therapy
Therapeutic Strategy.
指南简介
原文链接
SEOM Clinical Guidelines for Diagnosis and Treatment of Metastatic Colorectal Cancer (2018)
2019年 发布于
Clin Transl Oncol
21卷 第1期
所属人体系统:
消化
|
结直肠肿瘤
Spanish Society of Medical Oncology
Ablative Treatments
Chemotherapy
Colorectal Cancer
Frail Patients
Metastases
Surgery
Targeted Agents
指南简介
原文链接
Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: a National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
2019年 发布于
Actas Dermosifiliogr (Engl Ed)
110卷 第6期
所属人体系统:
其他
|
症状管理
Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
Chemotherapy
Cutaneous Toxicity
Dermatological Toxicity
Erupción
Fotosensibilidad
Hiperpigmentación
Hyperpigmentation
Photosensitivity
Quimioterapia
Rash
Toxicidad Cutánea
Toxicidad Dermatológica
Consensus
指南简介
原文链接
Classification of the Acute Emetogenicity of Chemotherapy in Pediatric Patients: a Clinical Practice Guideline
2019年 发布于
Pediatr Blood Cancer
66卷 第5期
所属人体系统:
其他
|
症状管理
无
Pediatric Patients
Chemotherapy
Acute Emetogenicity
Classification
Guideline
指南简介
原文链接
Anticoagulation of Cancer Patients with Non-valvular Atrial Fibrillation Receiving Chemotherapy: Guidance from the SSC of the ISTH
2019年 发布于
J Thromb Haemost
17卷 第8期
所属人体系统:
其他
|
症状管理
Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Cancer Patients
Non-valvular Atrial Fibrillation
Anticoagulation
Chemotherapy
Guideline
指南简介
原文链接
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018
2019年 发布于
Curr Oncol
26卷 第5期
所属人体系统:
消化
|
直肠癌
无
Guidelines
Chemotherapy
Colorectal Cancer
Hepatocellular Carcinoma
Pancreatic Cancer
Pancreatic Neuroendocrine Tumours
Radiation Therapy
Surgery.
指南简介
原文链接
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018
2019年 发布于
Curr Oncol
26卷 第5期
所属人体系统:
消化
|
结肠癌
无
Guidelines
Chemotherapy
Colorectal Cancer
Hepatocellular Carcinoma
Pancreatic Cancer
Pancreatic Neuroendocrine Tumours
Radiation Therapy
Surgery.
指南简介
原文链接
SIU-ICUD Recommendations on Bladder Cancer: Systemic Therapy for Metastatic Bladder Cancer
2019年 发布于
World J Urol
37卷 第1期
所属人体系统:
泌尿
|
膀胱肿瘤
Société Internationale D'UrologieInternational
Consultation on Urologic Diseases
Bladder Cancer
Checkpoint Inhibitors
Chemotherapy
Immunotherapy
Urothelial Cancer
指南简介
原文链接
SIU-ICUD Consultation on Bladder Cancer: Treatment of Muscle-invasive Bladder Cancer
2019年 发布于
World J Urol
37卷 第1期
所属人体系统:
泌尿
|
膀胱肿瘤
无
Adjuvant
Chemotherapy
Bladder-sparing
Chemoradiation
Enhanced Recovery after Surgery
Muscle-invasive Bladder Cancer
Neoadjuvant
Chemotherapy
Radical Cystectomy
Transurethral Resection of Bladder Tumor
Trimodal
Urothelial Carcinoma of Bladder
Variant Histology
指南简介
原文链接
SEOM Clinical Guideline for Treatment of Muscle-invasive and Metastatic Urothelial Bladder Cancer (2018)
2019年 发布于
Clin Transl Oncol
21卷 第1期
所属人体系统:
泌尿
|
膀胱肿瘤
Spanish Society of Medical Oncology
Bladder Cancer
Chemotherapy
Cystectomy
Immune Checkpoint Inhibitors
指南简介
原文链接
Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: the PENELOPE Project
2019年 发布于
Adv Ther
36卷 第2期
所属人体系统:
生殖
|
乳腺肿瘤
无
Breast Cancer
Consensus Meeting
Metronomic
Chemotherapy
Vinorelbine
指南简介
原文链接
French Recommendations on Strategies for Preventing and Treating Osteoporosis Induced by Adjuvant Breast Cancer Therapies
2019年 发布于
Joint Bone Spine
86卷 第5期
所属人体系统:
生殖
|
乳腺肿瘤
无
Aromatase Inhibitors
Bisphosphonates
Bone Loss
Breast Cancer
Chemotherapy
指南简介
原文链接
Childhood Cancer Treatments and Associated Endocrine Late Effects: a Concise Guide for the Pediatric Endocrinologist
2019年 发布于
Horm Res Paediatr
91卷 第2期
所属人体系统:
其他
|
治疗方案
无
Chemotherapy
Late-effects
Childhood Cancer Survivor
Endocrine Complications
Endocrine Late-effects
Radiotherapy Late-effects
指南简介
原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man
2019年 发布于
Gynecol Obstet Fertil Senol
47卷 第2期
所属人体系统:
其他
|
腹膜肿瘤
FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique)
Au CNGOF (Collège National Des Gynécologues Obstétriciens Français)
À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).
Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert
a Subjective Analysis Is Optimal. If Performed by a Non-expert
Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert)
a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert
a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading
the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian
Fallopian Tube Or Primary Peritoneal Cancer
It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2
Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency
GFR <30mL/min)
an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3
Grade C). by Analogy
the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant
Chemotherapy
(LP3
Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3
Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa
2019年 发布于
Eur J Obstet Gynecol Reprod Biol
236卷 第_期
所属人体系统:
其他
|
腹膜肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). Adjuvant
Chemotherapy
by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancers (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete
6 Cycles of Intravenous
Chemotherapy
(grade A) Are Recommended
Or a Discussion with the Patient About Intraperitoneal
Chemotherapy
According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease
Hyperthermic Intraperitoneal
Chemotherapy
(HIPEC) Can Be Proposed
in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors
Chemotherapy
Associated with Bevacizumab Is Recommended (grade A).
指南简介
原文链接
Use of Cannabinoids in Cancer Patients: a Society of Gynecologic Oncology (SGO) Clinical Practice Statement
2020年 发布于
Gynecol Oncol
157卷 第2期
所属人体系统:
其他
|
治疗方案
Society of Gynecologic Oncology
Anti-inflammatory Properties of Cannabis
Cannabinoids
Chemotherapy
Induced Nausea Vomiting
Medical Cannabis/medical Marijuana
Neuropathy Secondary to
Chemotherapy
Pain Management in Cancer.
指南简介
原文链接
Pressurised Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis
2020年 发布于
National Institute for Health and Care Excellence
卷 第期
所属人体系统:
其他
|
腹膜肿瘤
National Institute for Health and Care Excellence
Peritoneal Carcinomatosis
treatment
chemotherapy
指南简介
原文链接
首页
上一页
1
2
3
4
5
6
下一页
尾页
共109条,每页显示
20条
50条
100条
跳转至第
页
确定